{"id":"https://openalex.org/W4416630165","doi":"https://doi.org/10.1158/1078-0432.30709389","title":"Figure S1 from Subsets of IFN Signaling Predict Response to Immune Checkpoint Blockade in Patients with Melanoma","display_name":"Figure S1 from Subsets of IFN Signaling Predict Response to Immune Checkpoint Blockade in Patients with Melanoma","publication_year":2025,"publication_date":"2025-11-25","ids":{"openalex":"https://openalex.org/W4416630165","doi":"https://doi.org/10.1158/1078-0432.30709389"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.30709389","doi":"https://doi.org/10.1158/1078-0432.30709389","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30709389","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Figure_S1_from_Subsets_of_IFN_Signaling_Predict_Response_to_Immune_Checkpoint_Blockade_in_Patients_with_Melanoma/30709389/1/files/59834211.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Figure_S1_from_Subsets_of_IFN_Signaling_Predict_Response_to_Immune_Checkpoint_Blockade_in_Patients_with_Melanoma/30709389/1/files/59834211.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065832289","display_name":"Brooke Horowitch","orcid":"https://orcid.org/0000-0001-6499-978X","observed_orcids":["https://orcid.org/0000-0001-6499-978X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brooke Horowitch","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6499-978X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101955075","display_name":"Daniel Y. Lee","orcid":"https://orcid.org/0000-0001-9106-9342","observed_orcids":["https://orcid.org/0000-0001-9106-9342"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Y. Lee","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9106-9342","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034631075","display_name":"Min Ding","orcid":"https://orcid.org/0009-0006-6173-523X","observed_orcids":["https://orcid.org/0009-0006-6173-523X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Min Ding","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0006-6173-523X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069463643","display_name":"Sandra Mart\u00ednez-Morilla","orcid":"https://orcid.org/0000-0003-0931-4906","observed_orcids":["https://orcid.org/0000-0003-0931-4906"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sandra Martinez-Morilla","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0931-4906","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011946828","display_name":"Thazin Nwe Aung","orcid":"https://orcid.org/0000-0003-4150-0426","observed_orcids":["https://orcid.org/0000-0003-4150-0426"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thazin Nwe Aung","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4150-0426","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000678671","display_name":"Feriel Ouerghi","orcid":"https://orcid.org/0009-0000-7841-1713","observed_orcids":["https://orcid.org/0009-0000-7841-1713"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Feriel Ouerghi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-7841-1713","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100634477","display_name":"Xueting Wang","orcid":"https://orcid.org/0000-0002-1005-3072","observed_orcids":["https://orcid.org/0000-0002-1005-3072"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xueting Wang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1005-3072","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073006325","display_name":"Wei Wei","orcid":"https://orcid.org/0000-0003-1263-5620","observed_orcids":["https://orcid.org/0000-0003-1263-5620"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wei Wei","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1263-5620","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003399089","display_name":"William Damsky","orcid":"https://orcid.org/0000-0003-0975-4071","observed_orcids":["https://orcid.org/0000-0003-0975-4071"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William Damsky","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0975-4071","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102750517","display_name":"Mario Sznol","orcid":"https://orcid.org/0000-0003-4137-9662","observed_orcids":["https://orcid.org/0000-0003-4137-9662"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mario Sznol","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4137-9662","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001175430","display_name":"Harriet M. Kluger","orcid":"https://orcid.org/0000-0002-4932-9873","observed_orcids":["https://orcid.org/0000-0002-4932-9873"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Harriet Kluger","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4932-9873","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027326018","display_name":"David L. Rimm","orcid":"https://orcid.org/0000-0001-5820-4397","observed_orcids":["https://orcid.org/0000-0001-5820-4397"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David L. Rimm","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5820-4397","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5067516923","display_name":"Jeffrey Joseph Ishizuka","orcid":"https://orcid.org/0000-0002-4271-7312","observed_orcids":["https://orcid.org/0000-0002-4271-7312"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey J. Ishizuka","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4271-7312","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interferon-signaling","display_name":"interferon signaling","score":0.9750000238418579},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.9789999723434448},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tissue-microarray","display_name":"tissue microarray","score":0.5450000166893005},{"id":"https://openalex.org/keywords/cancer-cell-lines","display_name":"cancer cell lines","score":0.9629999995231628},{"id":"https://openalex.org/keywords/human-t-cells","display_name":"human T cells","score":0.9319999814033508},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.515999972820282}],"concepts":[{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.6866000294685364},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.6607000231742859},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6283000111579895},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6026999950408936},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.5307999849319458},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.48980000615119934},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.3896999955177307},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.3723999857902527},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3467999994754791},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.3402000069618225},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3310000002384186},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.30979999899864197},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.30660000443458557},{"id":"https://openalex.org/C2781053074","wikidata":"https://www.wikidata.org/wiki/Q21100639","display_name":"PD-L1","level":4,"score":0.3061999976634979},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.302700012922287},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.29739999771118164},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.28600001335144043},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.28450000286102295},{"id":"https://openalex.org/C21705690","wikidata":"https://www.wikidata.org/wiki/Q2907609","display_name":"CTLA-4","level":4,"score":0.2732999920845032},{"id":"https://openalex.org/C179185449","wikidata":"https://www.wikidata.org/wiki/Q219699","display_name":"Suppressor","level":3,"score":0.2718000113964081},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.2614000141620636},{"id":"https://openalex.org/C2780405999","wikidata":"https://www.wikidata.org/wiki/Q3483597","display_name":"Co-stimulation","level":5,"score":0.26080000400543213},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.25850000977516174},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.2572999894618988},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.251800000667572}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.30709389","doi":"https://doi.org/10.1158/1078-0432.30709389","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30709389","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Figure_S1_from_Subsets_of_IFN_Signaling_Predict_Response_to_Immune_Checkpoint_Blockade_in_Patients_with_Melanoma/30709389/1/files/59834211.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/30709389","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Figure_S1_from_Subsets_of_IFN_Signaling_Predict_Response_to_Immune_Checkpoint_Blockade_in_Patients_with_Melanoma/30709389","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.30709389","doi":"https://doi.org/10.1158/1078-0432.30709389","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30709389","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Figure_S1_from_Subsets_of_IFN_Signaling_Predict_Response_to_Immune_Checkpoint_Blockade_in_Patients_with_Melanoma/30709389/1/files/59834211.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4416630165.pdf","grobid_xml":"https://content.openalex.org/works/W4416630165.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4402776083","https://openalex.org/W4380569151","https://openalex.org/W4402802700","https://openalex.org/W4385457980","https://openalex.org/W4402800656","https://openalex.org/W4416630053","https://openalex.org/W4385457764","https://openalex.org/W4380569129","https://openalex.org/W4402800824","https://openalex.org/W4380628777"],"abstract_inverted_index":{"Supplemental":[0],"Figure":[1],"1:":[2],"Test":[3],"TMA":[4],"of":[5,15],"tumor":[6],"cell":[7],"lines":[8],"and":[9],"human":[10],"T":[11],"cells":[12],"for":[13],"validation":[14],"AQUA":[16],"signal":[17],"quantification.":[18]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2025-11-25T00:00:00"}